Kevin Weil's Warp Sciences Raises $215 Million at $865 Million Valuation
Summary
Kevin Weil, formerly OpenAI's science lead, launches Warp Sciences, an AI startup training robots to synthesize and test drug compounds. Weil says the company raised $215 million at an $865 million valuation, led by Lightspeed. He aims to reshore lab work now outsourced to Chinese contractors such as WuXi AppTec.
Key Points
- IVP, Premji Invest and Lux Capital join the round, Weil says.
- Human chemists wear cameras and sensor gloves to train the robots on lab tasks.
- Weil says automating wet-lab work lets robots run around the clock to speed drug discovery.